Friday, September 25, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

Compoundingrecallcompounding pharmacyfda

Pharmacy recalls compounded skin supplement over potentially deadly risk

NewsNation reports a compounding pharmacy pulled the product, a reminder of quality risks in the compounded injectables channel.

DO
By Daniel Okafor · Regulatory Correspondent
Sep 18 15:19 ETSource: NewsNation

The wire

  1. 01A compounding pharmacy has recalled a compounded skin supplement that could be deadly, according to NewsNation.
  2. 02Recalls in the compounded injectable and supplement space bear directly on 503A and 503B sourcing decisions by clinics and telehealth operators.
  3. 03Details on the product, the pharmacy, lot numbers and any reported harm were not available in the item; readers should check FDA recall notices for specifics.

From the source

Compounded skin supplement could be deadly, recalled by pharmacy

Read at newsnationnow.com
PeptiPrescribed peptides from $99/moSee all →